CREATE Medicines
PrivateLast Round
Series B
May 14, 2026
Total Funding Raised
$245M
Company Overview
CREATE Medicines is a clinical-stage biotechnology company that pioneers in vivo multi-immune programming to deliver scalable, repeat-dose, off-the-shelf immunotherapies for cancer, autoimmunity, and fibrosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CREATE Medicines Comps
Public and private peers based on sector, stage, and business model.
CREATE Medicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 14, 2026 | ||||
| Series A Extension | May 18, 2023 | ||||
| Series A | Jan 6, 2021 |
CREATE Medicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Newpath Partners | Series A Extension, Series A, Series B |
| ARCH Venture Partners | Series A Extension, Series B |
| Hatteras Venture Partners | Series A, Series A Extension, Series B |
| Alexandria Venture Investments | Series A, Series A Extension, Series B |
| 8VC | Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 14, 2026
$122M round led by ARCH Venture Partners, Hatteras Venture Partners, and Newpath Partners.
- May 18, 2023
$73M round led by Hatteras Venture Partners.
CREATE Medicines Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CREATE Medicines's valuation, stock price, and market status.
